Clinical Trials Browser

Phase 2 × Has results × COVID-19 × Clear all

NCT04377659 2025-05-28

Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection

Phase 2 Terminated

9 enrolled 8 charts

COVID-19, Respiratory Tract Infections

NCT04347226 2025-05-22

Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19

Phase 2 Terminated

43 enrolled 14 charts

Other hematologic neoplasm

COVID-19, Coronavirus Infections, Hematologic Neoplasms

NCT04466098 2025-01-29

Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)

Phase 2 Completed

8 enrolled 21 charts

Cytokine Release Syndrome, COVID-19, Lymphoma, Follicular, Respiratory Distress Syndrome

NCT05016622 2024-07-31

Booster Dose Trial

Phase 2 Terminated

106 enrolled 39 charts

COVID-19, Neoplasms

NCT04404361 2024-06-05

PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer

Phase 2 Terminated

200 enrolled 16 charts

COVID-19

NCT04358406 2023-11-28

Rhu-pGSN for Severe Covid-19 Pneumonia

Phase 2 Completed

64 enrolled 17 charts

Cytokine Release Syndrome, COVID-19, Lymphoma, Follicular, Pneumonia

NCT04381988 2021-10-27

A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy

Phase 2 Terminated

4 enrolled 5 charts

COVID-19, Neoplasms